Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis

SIMPLE SUMMARY: An increasing number of new systemic therapies have significantly enhanced treatment opportunities for patients with advanced liver cancer. Yet, it is unclear which sequence of systemic therapies is best for individual patients. In the present study, we compared systemic treatment li...

Descripción completa

Detalles Bibliográficos
Autores principales: Leyh, Catherine, Ehmer, Ursula, Roessler, Daniel, Philipp, Alexander B., Reiter, Florian P., Jeliazkova, Petia, Jochheim, Leonie S., Jeschke, Matthias, Hammig, Janina, Ludwig, Johannes M., Theysohn, Jens M., Geier, Andreas, Lange, Christian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025688/
https://www.ncbi.nlm.nih.gov/pubmed/35454881
http://dx.doi.org/10.3390/cancers14081975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025688/
https://www.ncbi.nlm.nih.gov/pubmed/35454881
http://dx.doi.org/10.3390/cancers14081975

Ejemplares similares